Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J LORD

Showing results (391-400 of 511) with videos related to

Pageof 52
Sort By:
Genome Research|December 21, 2011
Whole genome sequencing of matched primary and metastatic acral melanomasSamra Turajlic, Simon J Furney, Maryou B Lambros, et al.
British Journal of Cancer|April 14, 2015
MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinomaO M Fisher, A J Levert-Mignon, S J Lord, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2008
Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control studySarah J Lord, Leslie Bernstein, Karen A Johnson, et al.
Immunity|August 10, 2000
The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137P A Lyons, W W Hancock, P Denny, et al.
The Journal of Pathology|November 21, 2012
Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitorLouise J Barber, Shahneen Sandhu, Lina Chen, et al.
Annals of Surgical Oncology|January 4, 2021
Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA-D MelanomaRobin M Turner, Mbathio Dieng, Nikita Khanna, et al.
Nature|April 15, 2005
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategyHannah Farmer, Nuala McCabe, Christopher J Lord, et al.
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry|November 26, 2008
DCDHF fluorophores for single-molecule imaging in cellsSamuel J Lord, Nicholas R Conley, Hsiao-Lu D Lee, et al.
United European Gastroenterology Journal|April 14, 2017
Changes in gene expression of neo-squamous mucosa after endoscopic treatment for dysplastic Barrett's esophagus and intramucosal adenocarcinomaAngelique Levert-Mignon, Michael J Bourke, Sarah J Lord, et al.
Oncogene|July 26, 2023
A HUWE1 defect causes PARP inhibitor resistance by modulating the BRCA1-∆11q splice variantStephen J Pettitt, Nan Shao, Diana Zatreanu, et al.
Pageof 52

Showing results (391-400 of 511) with videos related to

Sort By:
Pageof 52
Genome Research|December 21, 2011
Whole genome sequencing of matched primary and metastatic acral melanomasSamra Turajlic, Simon J Furney, Maryou B Lambros, et al.
British Journal of Cancer|April 14, 2015
MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinomaO M Fisher, A J Levert-Mignon, S J Lord, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2008
Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control studySarah J Lord, Leslie Bernstein, Karen A Johnson, et al.
Immunity|August 10, 2000
The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137P A Lyons, W W Hancock, P Denny, et al.
The Journal of Pathology|November 21, 2012
Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitorLouise J Barber, Shahneen Sandhu, Lina Chen, et al.
Annals of Surgical Oncology|January 4, 2021
Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA-D MelanomaRobin M Turner, Mbathio Dieng, Nikita Khanna, et al.
Nature|April 15, 2005
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategyHannah Farmer, Nuala McCabe, Christopher J Lord, et al.
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry|November 26, 2008
DCDHF fluorophores for single-molecule imaging in cellsSamuel J Lord, Nicholas R Conley, Hsiao-Lu D Lee, et al.
United European Gastroenterology Journal|April 14, 2017
Changes in gene expression of neo-squamous mucosa after endoscopic treatment for dysplastic Barrett's esophagus and intramucosal adenocarcinomaAngelique Levert-Mignon, Michael J Bourke, Sarah J Lord, et al.
Oncogene|July 26, 2023
A HUWE1 defect causes PARP inhibitor resistance by modulating the BRCA1-∆11q splice variantStephen J Pettitt, Nan Shao, Diana Zatreanu, et al.
Pageof 52